Context:
A recent study shows an 86% decline in older PFAS (‘forever chemicals’) in human blood between 2003 and 2021, attributed to regulatory and manufacturing changes. However, new replacement compounds such as 9Cl-PF3ONS and Cl-PFNPA have emerged in human samples, raising fresh environmental and health concerns.
Key Highlights:
- Decline in Older PFAS
- Significant 86% reduction in legacy PFAS levels in blood.
- Reflects impact of regulatory bans and industrial phase-outs.
- Emergence of Replacement Compounds
- 9Cl-PF3ONS detected in 68% of individuals tested.
- Cl-PFNPA identified in human blood for the first time.
- These compounds are relatively less studied and poorly understood.
- Health & Environmental Concerns
- Potential for bioaccumulation and persistence similar to earlier PFAS.
- Uncertain long-term impacts on:
- Endocrine system
- Immune function
- Reproductive health
- Regulatory Challenge
- Replacement chemicals often enter markets before comprehensive risk assessment.
- Raises issue of “regrettable substitution” — replacing one harmful chemical with another insufficiently studied compound.
Scientific Concepts Involved:
- PFAS (Per- and Polyfluoroalkyl Substances):
- Synthetic chemicals used in non-stick cookware, firefighting foams, waterproof fabrics.
- Characterized by strong carbon-fluorine bonds → highly persistent.
- Bioaccumulation: Gradual accumulation in living organisms.
- Endocrine Disruption: Chemicals interfering with hormone systems.
Significance:
- Demonstrates success of policy-driven environmental regulation.
- Simultaneously highlights gaps in chemical governance frameworks.
- Signals need for precautionary principle in approving substitutes.
- Relevant in context of global efforts like Stockholm Convention on Persistent Organic Pollutants (POPs).
Relevant Prelims Points:
- PFAS are often called “forever chemicals” due to extreme environmental persistence.
- Found in:
- Water bodies
- Soil
- Human blood serum
- Associated health risks:
- Cancer
- Thyroid disorders
- Developmental effects
- Stockholm Convention (2001):
- Global treaty to eliminate/restrict POPs.
- Some PFAS compounds included in annexes.
- India is a party to the Stockholm Convention.
Relevant Mains Points:
- Environmental Governance Issues:
- Weak global framework for regulating emerging contaminants.
- Need for lifecycle-based chemical regulation.
- Science & Policy Interface:
- Lag between innovation and regulatory oversight.
- Importance of toxicological surveillance and biomonitoring.
- Public Health Dimension:
- Urban water contamination risks.
- Environmental justice concerns in industrial regions.
- Sustainable Development:
- Aligns with SDG 3 (Health) and SDG 12 (Responsible Consumption and Production).
Way Forward:
- Adopt group-based regulation instead of regulating individual PFAS compounds.
- Strengthen precautionary principle in chemical approvals.
- Expand biomonitoring programs in developing countries.
- Promote green chemistry alternatives.
UPSC Relevance:
GS Paper 3 – Environment & Ecology; Science & Technology
Prelims Focus: PFAS, POPs, Stockholm Convention, Bioaccumulation